Clinical Trial

Sense of Coherence and Quality of Life in Prostate Cancer Patients Treated With Radical Radiotherapy

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This prospective single-group interventional study evaluates the relationship between sense of coherence (SOC), health-related quality of life (HRQL), and self-rated health (SRH) in patients with prostate cancer treated with radical radiotherapy. The study aims to identify factors that may contribute to improved quality of life and coping after treatment. Participants complete validated questionnaires assessing HRQL (EORTC QLQ-C30), SOC (SOC-13), and self-rated health at predefined time points. In addition, objectively assessed treatment-related problems are evaluated using a structured physician-led interview. Data are collected before the start of radiotherapy, at the end of radiotherapy, and one year after completion of treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-19.
Trial Details
NCT Number NCT07431684
Lead Sponsor Institute of Oncology Ljubljana
Conditions Prostate Cancer
Enrollment 250 participants
Start Date 2021-09-01
Primary Completion 2023-09-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-03